Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.50 |
| ▸ | XDH | P47989 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.45 |
| ▸ | BRD4 | O60885 | 1/20 | 0.44 |
| ▸ | AURKA | O14965 | 1/20 | 0.44 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.44 |
| ▸ | PAK4 | O96013 | 1/20 | 0.44 |
| ▸ | ABL1 | P00519 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20253314 | 0.98 | MAPT (0.63) | MAPTSMN1; SMN2HSD17B1RAB9ACLK4 | |
| SCHEMBL30447126 | 0.80 | MAPT (0.57) | MAPTSMN1; SMN2ALDH1A1MAOBABL1 | |
| SCHEMBL933588 | 0.80 | MAPT (0.57) | MAPTSMN1; SMN2ALDH1A1MAOBABL1 | |
| SCHEMBL1222172 | 0.80 | MKNK1 (0.55) | RAB9ACLK4NPC1ALDH1A1 | |
| SCHEMBL23691953 | 0.79 | MAPT (0.60) | MAPTSMN1; SMN2HSD17B1RAB9AXDH | |
| SCHEMBL8365593 | 0.79 | MEN1 (0.47) | MAPTSMN1; SMN2HSD17B1RAB9AXDH | |
| SCHEMBL13617393 | 0.78 | MKNK1 (0.62) | MAPTSMN1; SMN2RAB9ANPC1ALDH1A1 | |
| SCHEMBL3553363 | 0.78 | CLK4 (0.45) | RAB9ACLK4NPC1ALDH1A1MAOB | |
| SCHEMBL197130 | 0.78 | MAPT (0.80) | MAPTSMN1; SMN2HSD17B1RAB9AXDH | |
| SCHEMBL11441494 | 0.78 | MAPT (0.80) | MAPTSMN1; SMN2HSD17B1RAB9AXDH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11358961-B2 | Anti-HCMV compositions and methods | EVRYS BIO, LLC (US) | 2022-06-14 | — | — | US | disclosed |
| US-20220135556-A1 | ANTI-HCMV COMPOSITIONS AND METHODS | EVRYS BIO, LLC (US) | 2022-05-05 | — | — | US | disclosed |
| EP-3218373-B1 | ANTI-HCMV COMPOSITIONS AND METHODS | EVRYS BIO LLC (US) | 2020-07-22 | — | — | EP | disclosed |
| US-20200140429-A1 | ANTI-HCMV COMPOSITIONS AND METHODS | EVRYS BIO, LLC (US) | 2020-05-07 | — | — | US | disclosed |
| US-10556894-B2 | Anti-HCMV compositions and methods | EVRYS BIO, LLC (US) | 2020-02-11 | — | — | US | disclosed |
| WO-2018105776-A1 | PHENANTHROLINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING SAME | 주식회사 진웅산업 | 2018-06-14 | — | — | WO | disclosed |
| WO-2016077232-A2 | ANTI-HCMV COMPOSITIONS AND METHODS | FORGE LIFE SCIENCE, LLC (US) | 2016-05-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11358961-B2 | Anti-HCMV compositions and methods | RPL35, RPL7, RPL5 | MAPT 1391/4885SMN1; SMN2 3438/4885HSD17B1 2444/4885 |
| US-10556894-B2 | Anti-HCMV compositions and methods | RPL35, RPL7, RPL5 | MAPT 1391/4885SMN1; SMN2 3438/4885HSD17B1 2444/4885 |
| US-20200140429-A1 | ANTI-HCMV COMPOSITIONS AND METHODS | RPL35, RPL7, RPL5 | MAPT 1391/4885SMN1; SMN2 3438/4885HSD17B1 2444/4885 |
| US-20220135556-A1 | ANTI-HCMV COMPOSITIONS AND METHODS | RPL35, RPL7, RPL5 | MAPT 1391/4885SMN1; SMN2 3438/4885HSD17B1 2444/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.